Our Principal, Susan Moring, joined CorriXR CEO, Deborah Moorad and CorriXR’s Founder and CSO, Eric B. Kmiec, in an exclusive interview with OETA. This insightful interview highlights the pioneering efforts this amazing company is making in transforming gene editing technology for cancer treatment.
Click the link to watch (21:39)
